Dr. Brian Jeffery Scott, MD

Dr. Scott practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Scott's NPI, 1356475222, was assigned on March 15, 2007. Dr. Scott graduated from Boonshoft School of Medicine in 2003. Dr. Scott holds California license A112539.

Dr. Scott's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Scott's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Scott to 1 more hospital and 1 medical group, each named with a free account. Dr. Scott's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Scott practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Scott's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Scott is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Scott's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists encephalopathy, head injury, migraine and chronic headache, muscle pain, fibromyalgia, and limb pain, nerve damage, seizures and thoracic spine disorders among the conditions Dr. Scott treats.

CMS data shows 243 Medicare services from Dr. Scott across 3 procedure codes in 2024, for 144 Medicare patients. Medicare paid $30,294 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 144 Medicare patients who saw Dr. Scott in 2024. The largest group is 65 to 74, with 60 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Scott's median patient age at 57, with 54% women.

In 2023, Dr. Scott wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $557 in total drug cost. In 2020, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Scott for performance year 2024, reported as part of a group. Dr. Scott accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 40 papers to Dr. Scott, published from 2010 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Immunotherapy, Adoptive, Dogs and Brain. Dr. Scott has published most often in Neurohospitalist. Dr. Scott's most frequent co-authors are Carl Aaron Gold, MD, Santosh Kesari, MD, PhD and Kathryn Andrea Kvam, MD.

Dmand AI links Dr. Scott to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Lymphoma, Non-Hodgkin and Lymphoma.

CMS Open Payments shows 6 general payments to Dr. Scott from 6 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Legend Biotech USA Inc. paid the most, $147.

Dr. Scott graduated from Boonshoft School of Medicine in 2003.

Dr. Scott is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.